Loading stock data…
$1.32
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia.
BioNexus Gene Lab Corp. in the Basic Materials sector is trading at $1.32 with a market capitalization of $4M. The stock is currently near its 52-week low of $1.07, remaining 38.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $76,156↑ | $22,842↓ | $483,760↓ | $2.54M↑ | $2.26M |
| Gross Profit | $12,982↑ | -$790↑ | -$3,983↓ | $377,685↑ | $368,022 |
| Operating Income | -$312,018↑ | -$571,433↑ | -$1.03M↓ | -$810,269↓ | -$699,993 |
| Net Income | -$286,451↑ | -$543,575↑ | -$1.04M↓ | -$708,991↓ | -$616,172 |
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and o...